Heparin and cilazapril together inhibit injury-induced intimai hyperplasia

Alexander W. Clowes, Monika M. Clowes, Selina C. Vergel, Rita K M Müller, Jerry S Powell, Fridolin Hefti, Hans R. Baumgartner

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Both heparin and the angiotensin converting enzyme inhibitor cilazapril inhibit intimai thickening in rat carotid arteries injured by the passage of a balloon catheter. The purpose of this study was to determine if combinations of the two drugs were more effective than either drug alone and whether the effect could be accounted for by inhibition of smooth muscle cell proliferation. Heparin (0.1-0.3 mg/kg/hr) administered by continuous intravenous infusion with or without cilazapril (0-25 mg/kg/day p.o.) produced a dose-dependent inhibition of smooth muscle accumulation at 14 days after rat carotid ballooning. At the lower doses, the inhibitory effects of heparin and cilazapril were additive when the drugs were used together. This overall effect on growth was reflected in decreased smooth muscle cell proliferation at 2 and 7 days. A 7-day course of heparin combined with cilazapril, a regimen that might be applicable in the clinical setting, produced an 80% inhibition of intimai thickening at 28 days. These results provide evidence that heparin and cilazapril together might prove to be more effective than either drug alone in the control of intimal hyperplasia after arterial injury.

Original languageEnglish (US)
JournalHypertension
Volume18
Issue number4 SUPPL.
StatePublished - 1991
Externally publishedYes

Fingerprint

Cilazapril
Hyperplasia
Heparin
Wounds and Injuries
Smooth Muscle Myocytes
Cell Proliferation
Pharmaceutical Preparations
Tunica Intima
Drug Combinations
Carotid Arteries
Angiotensin-Converting Enzyme Inhibitors
Intravenous Infusions
Smooth Muscle
Catheters
Growth

Keywords

  • Angiotensin converting enzyme inhibitors
  • Angiotensin II
  • Arteriosclerosis
  • Hyperplasia
  • Vascular smooth muscle

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Clowes, A. W., Clowes, M. M., Vergel, S. C., Müller, R. K. M., Powell, J. S., Hefti, F., & Baumgartner, H. R. (1991). Heparin and cilazapril together inhibit injury-induced intimai hyperplasia. Hypertension, 18(4 SUPPL.).

Heparin and cilazapril together inhibit injury-induced intimai hyperplasia. / Clowes, Alexander W.; Clowes, Monika M.; Vergel, Selina C.; Müller, Rita K M; Powell, Jerry S; Hefti, Fridolin; Baumgartner, Hans R.

In: Hypertension, Vol. 18, No. 4 SUPPL., 1991.

Research output: Contribution to journalArticle

Clowes, AW, Clowes, MM, Vergel, SC, Müller, RKM, Powell, JS, Hefti, F & Baumgartner, HR 1991, 'Heparin and cilazapril together inhibit injury-induced intimai hyperplasia', Hypertension, vol. 18, no. 4 SUPPL..
Clowes AW, Clowes MM, Vergel SC, Müller RKM, Powell JS, Hefti F et al. Heparin and cilazapril together inhibit injury-induced intimai hyperplasia. Hypertension. 1991;18(4 SUPPL.).
Clowes, Alexander W. ; Clowes, Monika M. ; Vergel, Selina C. ; Müller, Rita K M ; Powell, Jerry S ; Hefti, Fridolin ; Baumgartner, Hans R. / Heparin and cilazapril together inhibit injury-induced intimai hyperplasia. In: Hypertension. 1991 ; Vol. 18, No. 4 SUPPL.
@article{6845299805e448f58f8b1b45663a22ec,
title = "Heparin and cilazapril together inhibit injury-induced intimai hyperplasia",
abstract = "Both heparin and the angiotensin converting enzyme inhibitor cilazapril inhibit intimai thickening in rat carotid arteries injured by the passage of a balloon catheter. The purpose of this study was to determine if combinations of the two drugs were more effective than either drug alone and whether the effect could be accounted for by inhibition of smooth muscle cell proliferation. Heparin (0.1-0.3 mg/kg/hr) administered by continuous intravenous infusion with or without cilazapril (0-25 mg/kg/day p.o.) produced a dose-dependent inhibition of smooth muscle accumulation at 14 days after rat carotid ballooning. At the lower doses, the inhibitory effects of heparin and cilazapril were additive when the drugs were used together. This overall effect on growth was reflected in decreased smooth muscle cell proliferation at 2 and 7 days. A 7-day course of heparin combined with cilazapril, a regimen that might be applicable in the clinical setting, produced an 80{\%} inhibition of intimai thickening at 28 days. These results provide evidence that heparin and cilazapril together might prove to be more effective than either drug alone in the control of intimal hyperplasia after arterial injury.",
keywords = "Angiotensin converting enzyme inhibitors, Angiotensin II, Arteriosclerosis, Hyperplasia, Vascular smooth muscle",
author = "Clowes, {Alexander W.} and Clowes, {Monika M.} and Vergel, {Selina C.} and M{\"u}ller, {Rita K M} and Powell, {Jerry S} and Fridolin Hefti and Baumgartner, {Hans R.}",
year = "1991",
language = "English (US)",
volume = "18",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Heparin and cilazapril together inhibit injury-induced intimai hyperplasia

AU - Clowes, Alexander W.

AU - Clowes, Monika M.

AU - Vergel, Selina C.

AU - Müller, Rita K M

AU - Powell, Jerry S

AU - Hefti, Fridolin

AU - Baumgartner, Hans R.

PY - 1991

Y1 - 1991

N2 - Both heparin and the angiotensin converting enzyme inhibitor cilazapril inhibit intimai thickening in rat carotid arteries injured by the passage of a balloon catheter. The purpose of this study was to determine if combinations of the two drugs were more effective than either drug alone and whether the effect could be accounted for by inhibition of smooth muscle cell proliferation. Heparin (0.1-0.3 mg/kg/hr) administered by continuous intravenous infusion with or without cilazapril (0-25 mg/kg/day p.o.) produced a dose-dependent inhibition of smooth muscle accumulation at 14 days after rat carotid ballooning. At the lower doses, the inhibitory effects of heparin and cilazapril were additive when the drugs were used together. This overall effect on growth was reflected in decreased smooth muscle cell proliferation at 2 and 7 days. A 7-day course of heparin combined with cilazapril, a regimen that might be applicable in the clinical setting, produced an 80% inhibition of intimai thickening at 28 days. These results provide evidence that heparin and cilazapril together might prove to be more effective than either drug alone in the control of intimal hyperplasia after arterial injury.

AB - Both heparin and the angiotensin converting enzyme inhibitor cilazapril inhibit intimai thickening in rat carotid arteries injured by the passage of a balloon catheter. The purpose of this study was to determine if combinations of the two drugs were more effective than either drug alone and whether the effect could be accounted for by inhibition of smooth muscle cell proliferation. Heparin (0.1-0.3 mg/kg/hr) administered by continuous intravenous infusion with or without cilazapril (0-25 mg/kg/day p.o.) produced a dose-dependent inhibition of smooth muscle accumulation at 14 days after rat carotid ballooning. At the lower doses, the inhibitory effects of heparin and cilazapril were additive when the drugs were used together. This overall effect on growth was reflected in decreased smooth muscle cell proliferation at 2 and 7 days. A 7-day course of heparin combined with cilazapril, a regimen that might be applicable in the clinical setting, produced an 80% inhibition of intimai thickening at 28 days. These results provide evidence that heparin and cilazapril together might prove to be more effective than either drug alone in the control of intimal hyperplasia after arterial injury.

KW - Angiotensin converting enzyme inhibitors

KW - Angiotensin II

KW - Arteriosclerosis

KW - Hyperplasia

KW - Vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=0025986806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025986806&partnerID=8YFLogxK

M3 - Article

C2 - 1833326

AN - SCOPUS:0025986806

VL - 18

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4 SUPPL.

ER -